TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 88 filers reported holding TRINITY BIOTECH PLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $761,000 | +15.5% | 57,601 | -0.9% | 0.19% | +9.2% |
| Q2 2016 | $659,000 | +3.3% | 58,101 | +6.2% | 0.17% | +9.4% |
| Q1 2016 | $638,000 | +2.7% | 54,701 | +3.6% | 0.16% | +17.8% |
| Q4 2015 | $621,000 | -80.0% | 52,801 | -80.6% | 0.14% | -79.3% |
| Q3 2015 | $3,110,000 | -32.6% | 271,860 | +6.4% | 0.65% | -20.8% |
| Q2 2015 | $4,615,000 | -6.3% | 255,559 | -0.1% | 0.82% | -5.3% |
| Q1 2015 | $4,923,000 | +9.9% | 255,759 | -0.0% | 0.87% | +6.1% |
| Q4 2014 | $4,480,000 | +590.3% | 255,859 | +620.7% | 0.82% | +576.9% |
| Q3 2014 | $649,000 | -21.7% | 35,500 | -1.4% | 0.12% | -13.6% |
| Q2 2014 | $829,000 | -15.8% | 36,000 | -11.3% | 0.14% | -10.8% |
| Q1 2014 | $984,000 | -21.7% | 40,600 | -18.8% | 0.16% | -24.5% |
| Q4 2013 | $1,257,000 | +15.5% | 50,000 | 0.0% | 0.21% | -1.9% |
| Q3 2013 | $1,088,000 | +29.2% | 50,000 | 0.0% | 0.21% | +12.2% |
| Q2 2013 | $842,000 | – | 50,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |